MedPath

Difference in Central Fatigue During Two Ultra-endurance Practices: Running vs. Cycling

Not Applicable
Completed
Conditions
Ultra-marathon Runners
Interventions
Other: maximum effort test on a treadmill
Other: maximum effort test on a cycloergometer
Registration Number
NCT04511858
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The mechanisms contributing to muscle fatigue in extreme long-duration exercise bouts are poorly understood. Ultra-endurance exercise is an excellent model for the study of adaptive responses to extreme loads and stress and it is an especially useful model for documenting the origins of central fatigue. This protocol will compare fatigue during and after ultra-endurance exercise bouts that result in moderate lower-limb tissue damage (i.e. cycling) or significant damage (i.e. running). The results of this protocol will allow us to further understanding of the reasons for major central fatigue, i.e. within the central nervous system, in ultra-endurance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
19
Inclusion Criteria
  • Specialist in endurance and ultra-endurance. in the 2 disciplines: running and cycling (triathletes, duathletes or trailers achieving at least 30% of their training volume in cycling), and having at least finished one long distance event in the last 2 years,
  • Affiliated or beneficiary of a social security scheme.
  • Signature of the consent form
Exclusion Criteria
  • Any subject who has been injured in the 3 months prior to the protocol

  • Anyone with chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems).

  • Any subject with chronic or central neurological pathologies

  • Any subject with a contraindication to magnetic stimulation

  • Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) on the study.

  • Contraindication to the application of a magnetic field:

    • Heart or respiratory insufficiency.
    • Subject with a cardiac pace maker.
    • Cardiac valve wear and serious cardiovascular diseases.
    • Presence of prosthetic material or ferromagnetic foreign bodies in the head.
    • Presence of cochlear implants or ocular prosthetic material.
    • History of neurosurgical interventions.
    • Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumour, multiple sclerosis, history of stroke or traumatic brain injury).
    • History of comitiality, contralateral knee disease or musculoskeletal disease.
  • Any subject participating at the same time in another interventional experiment requiring physical exercise.

  • Any subject who has taken corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).

  • Any subject under guardianship or curatorship

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Running endurancemaximum effort test on a treadmillAthletes wiil run for 5 hours in a row.
Cycling endurancemaximum effort test on a cycloergometerAthletes wiil cycle for 5 hours in a row.
Primary Outcome Measures
NameTimeMethod
Maximum level of voluntary activation of relative central fatigueBefore and immediately after 5h exercise

measured in isometric mode of the knee extensors, between the value before and immediately after a 5-hour cycling or running event at the same relative intensity

Secondary Outcome Measures
NameTimeMethod
Maximum level of voluntary activation of fatigue centrale absoluteBefore and immediately after 5h exercise

measured in isometric mode of the knee extensors, between the value before the 5h cycling or running and the value after absolute exhaustion

Cortical excitabilityBefore and immediately after 5h exercise

ratio between stimulation of the motor cortex and thoracic spine stimulation

Measurement of isometric force valuesBefore and immediately after 5h exercise

subjects sitting on a Cybex type seat, with the knee and hip angle set at 90°. The foot will be attached to a strain-gauge sensor using a velcro strap attached to the ankle above the medial malleolus.

PlateletsBefore and immediately after 5h exercise

blood sample

HemoglobinBefore and immediately after 5h exercise

blood sample

C-reactive proteinBefore and immediately after 5h exercise

blood sample

Maximum level of voluntary activation with electrical evoked activationBefore and immediately after 5h exercise

tests with measurement of the maximum voluntary with evoked electrical between the value before and immediately after a 5-hour cycling or running event at the same relative intensity

Spinal excitabilityBefore and immediately after 5h exercise

thoracic spine stimulation for the recording of thoracic motor evoked potentials

Red blood cellsBefore and immediately after 5h exercise

blood sample

Measurement of the time maintained at the speed corresponding to the 2nd ventilatory thresholdBefore and immediately after 5h exercise

On treadmill

Corticospinal excitabilityBefore and immediately after 5h exercise

stimulation of the motor cortex for recording motor evoked potentials

Measurement of speed, force and power valuesBefore and immediately after 5h exercise

assessment of fatigue in dynamic mode (calculation of the force/speed profile)

Mean corpuscular hemoglobin concentrationBefore and immediately after 5h exercise

blood sample

Creatine PhosphoKinaseBefore and immediately after 5h exercise

blood sample

InterleukinesBefore and immediately after 5h exercise

blood sample

White blood cellsBefore and immediately after 5h exercise

blood sample

LactateBefore and immediately after 5h exercise

blood sample

measurement of the time maintained at the power corresponding to the 2nd ventilatory thresholdBefore and immediately after 5h exercise

On Cycloergometer

Trial Locations

Locations (1)

CHU Saint-Etienne

🇫🇷

Saint-Étienne, France

© Copyright 2025. All Rights Reserved by MedPath